Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × dostarlimab × Gynecologic × Clear all

Phase

Status

Recruiting 9 Active not recruiting 8 Withdrawn 4 Unknown 4 Not yet recruiting 3 Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Sarcoma 2 Thoracic 1 Plasma cell 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 CNS 1

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 60 Carboplatin 57 Cisplatin 31 pembrolizumab 30 liposomal doxorubicin 22 Cyclophosphamide 20 Topotecan 18 Gemcitabine 17 Bevacizumab 17 niraparib 12 Docetaxel 12 Nivolumab 11 fludarabine 10 Taxes 10 aldesleukin 7 Surveys and Questionnaires 7 Radiotherapy 7 Doxorubicin 7 olaparib 6 fludarabine phosphate 6 avelumab 6 Oxaliplatin 6 Interleukin-2 6 Hyperthermic Intraperitoneal Chemotherapy 6 Cytoreduction Surgical Procedures 6 1-dodecylpyridoxal 6 rucaparib 5 oregovomab 5 durvalumab 5 Magnetic Resonance Spectroscopy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03955471 2022-09-10

MOONSTONE

Tesaro, Inc.

Phase 2 Terminated

41 enrolled 22 charts

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡